Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa

[1]  C. Rouzioux,et al.  Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Egger,et al.  Early Mortality and Loss to Follow-up in HIV-Infected Children Starting Antiretroviral Therapy in Southern Africa , 2010, Journal of acquired immune deficiency syndromes.

[3]  F. Dabis,et al.  Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme. , 2010, Bulletin of the World Health Organization.

[4]  Organización Mundial de la Salud,et al.  Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009 , 2009 .

[5]  G. Gottlieb,et al.  A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa. , 2008, AIDS.

[6]  W. Moss,et al.  Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. , 2008, The Lancet. Infectious diseases.

[7]  M. Nolan,et al.  Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire. , 2008, AIDS research and human retroviruses.

[8]  F. Brun-Vézinet,et al.  Quality Control Assessment of Human Immunodeficiency Virus Type 2 (HIV-2) Viral Load Quantification Assays: Results from an International Collaboration on HIV-2 Infection in 2006 , 2008, Journal of Clinical Microbiology.

[9]  B. Chi,et al.  Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. , 2007, JAMA.

[10]  L. Koenig,et al.  Trends in Opportunistic Infections in the Pre–and Post–Highly Active Antiretroviral Therapy Eras Among HIV-Infected Children in the Perinatal AIDS Collaborative Transmission Study, 1986–2004 , 2007, Pediatrics.

[11]  J. Overbaugh,et al.  Early Response to Highly Active Antiretroviral Therapy in HIV-1-Infected Kenyan Children , 2007, Journal of acquired immune deficiency syndromes.

[12]  Sarah C Leeper,et al.  Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa , 2007, BMC pediatrics.

[13]  A. Walker,et al.  Nevirapine Concentrations in HIV-Infected Children treated with Divided Fixed-Dose Combination Antiretroviral Tablets in Malawi and Zambia , 2007, Antiviral therapy.

[14]  Julian Gold,et al.  Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. , 2007 .

[15]  R. Zachariah,et al.  In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy , 2006, AIDS.

[16]  M. Muñoz-Fernández,et al.  Impact of long-term viral suppression in CD4+ recovery of HIV-children on Highly Active Antiretroviral Therapy , 2006, BMC infectious diseases.

[17]  C. Duncombe,et al.  Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children adolescents and adults. Recommendations for a public health approach. , 2006 .

[18]  Arrivé Elise,et al.  Assessment of Adherence to Highly Active Antiretroviral Therapy in a Cohort of African HIV-Infected Children in Abidjan, Côte d'Ivoire , 2005, Journal of acquired immune deficiency syndromes.

[19]  E. Capparelli,et al.  Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine , 2005, AIDS.

[20]  I. Diagne,et al.  Aspects épidémiologiques et cliniques de l'infection à VIH de l'enfant au centre hospitalier national d'enfants Albert-Royer à Dakar , 2005 .

[21]  I. Diagne,et al.  [Epidemiological and clinical aspects of paediatric HIV infections in Albert-Royer Paediatric Hospital (Dakar, Senegal)]. , 2005, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[22]  S. Blanche,et al.  Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire , 2004, AIDS.

[23]  W. Heneine,et al.  Susceptibility of HIV-2, Siv and Shiv to Various Anti-HIV-1 Compounds: Implications for Treatment and Postexposure Prophylaxis , 2004, Antiviral therapy.

[24]  H. Whittle,et al.  Survival of HIV-1 and HIV-2 perinatally infected children in The Gambia , 2003, AIDS.

[25]  W. Heneine,et al.  Antiretroviral therapy in HIV‐2‐infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire , 2003, AIDS.

[26]  H. Whittle,et al.  Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia , 2002, AIDS.

[27]  M. Chesney,et al.  The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  J. Margolick,et al.  Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy. , 2001 .

[29]  H. Whittle,et al.  Maternal HIV-1 and HIV-2 infection and child survival in The Gambia , 2000, AIDS.

[30]  H. Whittle,et al.  Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. , 2000, AIDS.

[31]  A. Mocroft,et al.  Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. , 1999, AIDS.

[32]  I. Thior,et al.  Reduced rate of disease development after HIV-2 infection as compared to HIV-1. , 1994, Science.

[33]  H. Gayle,et al.  Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. , 1994, JAMA.

[34]  F. Dias,et al.  A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. , 1993, AIDS.

[35]  R. Yogev,et al.  Lymphocyte subsets in healthy children during the first 5 years of life. , 1992, JAMA.

[36]  H. Whittle,et al.  AIDS following mother-to-child transmission of HIV-2. , 1990, AIDS.

[37]  S. Chamaret,et al.  Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. , 1987, The New England journal of medicine.